![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Völkl, Matthias 
ORCID: https://orcid.org/0000-0002-8750-8733; Burgers, Luisa D. ORCID: https://orcid.org/0000-0001-7504-1104; Zech, Thomas Josef; Ciurus, Sarah; Dorovska, Senta; Liu, Hong; Zahler, Stefan ORCID: https://orcid.org/0000-0002-5140-7287 und Fürst, Robert ORCID: https://orcid.org/0000-0002-9926-7578
(2025):
Homoharringtonine (omacetaxine mepesuccinate) limits the angiogenic capacity of endothelial cells and reorganises filamentous actin.
In: Biomedicine & Pharmacotherapy, Bd. 186, 118025
[PDF, 5MB]
ORCID: https://orcid.org/0000-0002-8750-8733; Burgers, Luisa D. ORCID: https://orcid.org/0000-0001-7504-1104; Zech, Thomas Josef; Ciurus, Sarah; Dorovska, Senta; Liu, Hong; Zahler, Stefan ORCID: https://orcid.org/0000-0002-5140-7287 und Fürst, Robert ORCID: https://orcid.org/0000-0002-9926-7578
(2025):
Homoharringtonine (omacetaxine mepesuccinate) limits the angiogenic capacity of endothelial cells and reorganises filamentous actin.
In: Biomedicine & Pharmacotherapy, Bd. 186, 118025
[PDF, 5MB]
Burgers, Luisa D.; Li, Yanfen; Michalakis, Stylianos; Ciurus, Sarah; Zahler, Stefan; Mueller, Rolf und Fuerst, Robert
(2022):
The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2and TAZ-signaling.
In: Biomedicine & Pharmacotherapy, Bd. 152, 113174
Burgers, Luisa D.; Luong, Betty; Li, Yanfen; Fabritius, Matthias P.; Michalakis, Stylianos; Reichel, Christoph A.; Mueller, Rolf und Fuerst, Robert
(2021):
The natural product vioprolide A exerts anti-inflammatory actions through inhibition of its cellular target NOP14 and downregulation of importin-dependent NF-kappa B p65 nuclear translocation.
In: Biomedicine & Pharmacotherapy, Bd. 144, 112255